152 related articles for article (PubMed ID: 26369427)
1. Bioactive compounds of Eriocaulon sieboldianum blocking proliferation and inducing apoptosis of HepG2 cells might be involved in Aurora kinase inhibition.
Fan Y; Lu H; Ma H; Feng F; Hu X; Zhang Q; Wang J; Xu Y; Zhao Q
Food Funct; 2015 Dec; 6(12):3746-59. PubMed ID: 26369427
[TBL] [Abstract][Full Text] [Related]
2. Effect of active fraction of Eriocaulon sieboldianum on human leukemia K562 cells via proliferation inhibition, cell cycle arrest and apoptosis induction.
Fan Y; Lu H; An L; Wang C; Zhou Z; Feng F; Ma H; Xu Y; Zhao Q
Environ Toxicol Pharmacol; 2016 Apr; 43():13-20. PubMed ID: 26923230
[TBL] [Abstract][Full Text] [Related]
3. Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships.
Jung Y; Shin SY; Yong Y; Jung H; Ahn S; Lee YH; Lim Y
Chem Biol Drug Des; 2015 May; 85(5):574-85. PubMed ID: 25298094
[TBL] [Abstract][Full Text] [Related]
4. LRD-22, a novel dual dithiocarbamatic acid ester, inhibits Aurora-A kinase and induces apoptosis and cell cycle arrest in HepG2 cells.
Wang H; Li R; Li L; Ge Z; Zhou R; Li R
Biochem Biophys Res Commun; 2015 Feb; 458(1):201-7. PubMed ID: 25645017
[TBL] [Abstract][Full Text] [Related]
5. A thienopyrimidine derivative induces growth inhibition and apoptosis in human cancer cell lines via inhibiting Aurora B kinase activity.
Li J; Hu H; Lang Q; Zhang H; Huang Q; Wu Y; Yu L
Eur J Med Chem; 2013 Jul; 65():151-7. PubMed ID: 23707920
[TBL] [Abstract][Full Text] [Related]
6. Optimization and biological evaluation of 2-aminobenzothiazole derivatives as Aurora B kinase inhibitors.
Lee E; An Y; Kwon J; Kim KI; Jeon R
Bioorg Med Chem; 2017 Jul; 25(14):3614-3622. PubMed ID: 28529042
[TBL] [Abstract][Full Text] [Related]
7. Aurora kinases as targets in drug-resistant neuroblastoma cells.
Michaelis M; Selt F; Rothweiler F; Löschmann N; Nüsse B; Dirks WG; Zehner R; Cinatl J
PLoS One; 2014; 9(9):e108758. PubMed ID: 25268132
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition.
Fan C; Zhong T; Yang H; Yang Y; Wang D; Yang X; Xu Y; Fan Y
Eur J Med Chem; 2020 Mar; 190():112108. PubMed ID: 32058239
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of Aurora A and B kinases effectively induces cell cycle arrest in t(8;21) acute myeloid leukemia.
Qi J; Gao X; Zhong X; Zhang N; Wang R; Zhang H; Pan T; Liu X; Yao Y; Wu Q; Niu M; Xu K
Biomed Pharmacother; 2019 Sep; 117():109113. PubMed ID: 31207577
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of BPR1K653 derivatives targeting the back pocket of Aurora kinases for selective isoform inhibition.
Ke YY; Chang CP; Lin WH; Tsai CH; Chiu IC; Wang WP; Wang PC; Chen PY; Lin WH; Chang CF; Kuo PC; Song JS; Shih C; Hsieh HP; Chi YH
Eur J Med Chem; 2018 May; 151():533-545. PubMed ID: 29656197
[TBL] [Abstract][Full Text] [Related]
11. Effects of selective inhibitors of Aurora kinases on anaplastic thyroid carcinoma cell lines.
Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Gnessi L; Morrone S; Moretti C; Bononi M; Arlot-Bonnemains Y; D'Armiento M; Ulisse S
Endocr Relat Cancer; 2014 Oct; 21(5):797-811. PubMed ID: 25074669
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and molecular modeling study of 2-amino-3,5-disubstituted-pyrazines as Aurora kinases inhibitors.
Bo YX; Xiang R; Xu Y; Hao SY; Wang XR; Chen SW
Bioorg Med Chem; 2020 Mar; 28(5):115351. PubMed ID: 32035750
[TBL] [Abstract][Full Text] [Related]
13. New Treatment of Medullary and Papillary Human Thyroid Cancer: Biological Effects of Hyaluronic Acid Hydrogel Loaded With Quercetin Alone or in Combination to an Inhibitor of Aurora Kinase.
Quagliariello V; Armenia E; Aurilio C; Rosso F; Clemente O; de Sena G; Barbarisi M; Barbarisi A
J Cell Physiol; 2016 Aug; 231(8):1784-95. PubMed ID: 26660542
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 4-aminoquinazoline--urea derivatives as Aurora kinase inhibitors with antiproliferative activity.
Cai J; Li L; Hong KH; Wu X; Chen J; Wang P; Cao M; Zong X; Ji M
Bioorg Med Chem; 2014 Nov; 22(21):5813-23. PubMed ID: 25270403
[TBL] [Abstract][Full Text] [Related]
15. The synthesis and anti-tumour properties of novel 4-substituted phthalazinones as Aurora B kinase inhibitors.
Zhang XJ; Xu Y; Mou HX; Wang S; Hao SY; Chen SW
Bioorg Med Chem Lett; 2020 Dec; 30(23):127556. PubMed ID: 32941989
[TBL] [Abstract][Full Text] [Related]
16. Discovery of 7-aryl-substituted (1,5-naphthyridin-4-yl)ureas as aurora kinase inhibitors.
Defaux J; Antoine M; Le Borgne M; Schuster T; Seipelt I; Aicher B; Teifel M; Günther E; Gerlach M; Marchand P
ChemMedChem; 2014 Jan; 9(1):217-32. PubMed ID: 24273104
[TBL] [Abstract][Full Text] [Related]
17. The dual Aurora kinase inhibitor ZM447439 prevents anaplastic thyroid cancer cell growth and tumorigenicity.
Baldini E; Tuccilli C; Prinzi N; Sorrenti S; Antonelli A; Gnessi L; Catania A; Moretti C; Mocini R; Carbotta G; Morrone S; Persechino S; Redler A; De Antoni E; D' Armiento M; Ulisse S
J Biol Regul Homeost Agents; 2013; 27(3):705-15. PubMed ID: 24152827
[TBL] [Abstract][Full Text] [Related]
18. DNA replication stress in CHK1-depleted tumour cells triggers premature (S-phase) mitosis through inappropriate activation of Aurora kinase B.
Zuazua-Villar P; Rodriguez R; Gagou ME; Eyers PA; Meuth M
Cell Death Dis; 2014 May; 5(5):e1253. PubMed ID: 24853431
[TBL] [Abstract][Full Text] [Related]
19. Preclinical testing of selective Aurora kinase inhibitors on a medullary thyroid carcinoma-derived cell line.
Tuccilli C; Baldini E; Prinzi N; Morrone S; Sorrenti S; Filippini A; Catania A; Alessandrini S; Rendina R; Coccaro C; D'Armiento M; Ulisse S
Endocrine; 2016 May; 52(2):287-95. PubMed ID: 26215279
[TBL] [Abstract][Full Text] [Related]
20. Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance.
Li M; Liu H; Zhao Q; Han S; Zhou L; Liu W; Li W; Gao F
Cell Death Dis; 2021 Feb; 12(2):152. PubMed ID: 33542222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
